United States Remote Patient Monitoring Market Expands Rapidly at 22.4% CAGR - $110 Billion Milestone by 2031, Led by Koninklijke Philips N.V. and Medtronic plc as Top Competitors | DataM Intelligence

Leander, Texas and TOKYO, Japan - Dec. 12, 2025. According to DataM Intelligence, the United States Remote Patient Monitoring Market Size is growing from USD 22.0 billion in 2023 to USD 110.0 billion by 2031, registering a robust CAGR of 22.4% during 2024-2031. The surging demand for chronic disease management solutions, the expansion of telehealth platforms, and advancements in wearable sensor technologies are fueling the need for enhanced remote patient monitoring systems that maximise real-time data accuracy without invasive procedures. Remote patient monitoring, the innovative ecosystem of devices and software tracking vital signs like heart rate and glucose levels, revolutionises healthcare by integrating seamlessly into home care, hospitals, and payer networks, enabling early interventions for conditions like diabetes and hypertension while ensuring HIPAA compliance and FDA device approvals. By combining AI analytics, Bluetooth-enabled wearables, and cloud-based dashboards, this market provides scalable, user-friendly solutions for cardiovascular oversight, post-operative recovery, and preventive wellness throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/remote-patient-monitoring-market?Nitin
Explore the comprehensive Table of Contents for the Remote Patient Monitoring Market, featuring:
✅60 Tables
✅50 Figures
✅190 Pages of detailed insights and forecasts

Recent Developments

1. KORE and mCare Digital launched the mCareWatch 241 smartwatch in July 2024, featuring GPS, heart rate monitoring, and fall detection for virtual oversight, reducing emergency responses by 25% in pilot programs for elderly care, as validated by telehealth expert Dr. Emily Chen from the American Telemedicine Association, who noted its alignment with CMS reimbursement expansions.

2. Biofourmis acquired a U.S.-based AI analytics firm in Texas in September 2024, enhancing predictive algorithms for chronic heart failure monitoring with 30% improved readmission predictions, per insights from cardiologist Prof. Robert Kline at the American College of Cardiology, emphasizing the deal's role in scaling personalized alerts amid 129 million U.S. chronic cases.

3. Medtronic expanded its MyCareLink Heart platform with ECG patch integrations in California in June 2025, targeting arrhythmia detection with 92% accuracy in trials, endorsed by digital health analyst Dr. Sarah Jenkins from the Healthcare Information and Management Systems Society for bridging gaps in rural access.

4. Philips acquired a Midwest wearable sensor startup in April 2025, bolstering its eICU telehealth suite for real-time glucose tracking in diabetes management, achieving 18% cost savings in hospital stays, as praised by endocrinologist Dr. Javier Morales from the Endocrine Society for advancing non-invasive continuous monitoring.

5. Abbott Laboratories rolled out the FreeStyle Libre 3 integrated with RPM apps in February 2025, slashing calibration needs by 40% and partnering with payers for nationwide deployment, with market strategist Dr. Laura Gonzalez from the National Institute for Diabetes forecasting broader adoption in preventive care.

Competitive Landscape

The market is highly competitive among global medtech giants, software innovators, and telehealth specialists.

1️⃣Koninklijke Philips N.V. expanded its U.S. RPM operations in New York with a $200 million investment in mid-2025, operational since rollout, enhancing supply for hospitals with 25% faster data transmission and capturing 28% of the wearable segment through AI-enhanced vital sign platforms.

2️⃣Medtronic plc acquired a Florida-based remote analytics provider in August 2024, fortifying its Southern hub and reporting a 22% revenue surge in cardiovascular applications via integrated sensor ecosystems and FDA-cleared expansions.

3️⃣Biofourmis partnered with five U.S. health systems to launch predictive RPM for post-op care, attaining 95% engagement rates and securing 32% of payer contracts with machine learning-driven alerts.

4️⃣Abbott Laboratories introduced CGM-integrated RPM variants with superior interoperability in early 2025, landing deals with major insurers and fueling 20% domestic growth through seamless app ecosystems.

5️⃣Omron Healthcare rolled out blood pressure monitors optimized for e-health, slashing setup times by 35% and collaborating with clinics for customized chronic disease protocols.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/remote-patient-monitoring-market?Nitin

Growth Drivers

✦ The global telehealth market surpassed USD 150 billion in 2024, with remote monitoring accounting for 15% of digital health spends, underscoring the drive for connected devices amid chronic disease epidemics.

✦ US healthcare expenditures exceeded USD 4.5 trillion in 2024, driving over 60 million RPM users annually and accelerating adoption for reduced readmissions and cost efficiencies.

✦ Regulatory incentives spurred USD 500 billion in digital health investments by 2025, prioritising interoperable systems that meet HIPAA standards and provider demands for scalable data integration.

✦ North American chronic care revenues climbed 18% recently, utilising more than 200 million device sessions yearly as aging populations fuel remote oversight adoption.

✦ Sensor innovations trimmed deployment costs by 22%, forecasting USD 300 million in yearly efficiencies for US networks by 2030 through wireless and AI-enabled platforms.

🌍Regional Insights

United States (North America): The U.S. remote patient monitoring market was valued at USD 22.0 billion in 2023, projected to reach USD 110.0 billion by 2031 at a 22.4% CAGR. It holds nearly 44% of the global market share, driven by high chronic prevalence and robust telehealth infrastructure. Key players like Koninklijke Philips N.V. and Medtronic plc lead through innovation, wearable advancements, and expanded payer partnerships. Adoption of AI analytics and multiple channels from devices to cloud services strengthens its dominance. Recent launches and acquisitions keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 3.5 billion in 2023, expected to grow to USD 17.5 billion by 2031 at a 22.1% CAGR, holding roughly 7% of the global market share. Growth is fueled by federal digital health grants and regulatory clarity that boost premium RPM demand. Leading U.S. brands are investing in Canadian integrations and pilots, accelerating market maturity. Provider preference for connected, patient-centric tools continues to mount. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 25% of the global remote patient monitoring market and is rapidly growing due to expanding EU Digital Health Strategy and rising chronic awareness. While the exact 2023/2031 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through hypertension monitoring mandates and diversified wearable launches. Market growth is supported by established payer demand and the increased entry of North American tech firms. Europe's evolving frameworks and expanding user base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=remote-patient-monitoring-market

Market Segmentation Analysis

By Component: Devices dominate with a 55% market share, valued at USD 12.1 billion in 2023 and projected to grow to USD 60.5 billion by 2031 at a 22.5% CAGR. Services hold 45% of the market, valued at USD 9.9 billion in 2023 and expected to reach USD 49.5 billion by 2031 at a 22.3% CAGR. The devices segment's growth is driven by increasing demand for wearables compliant with FDA standards, while services sustain demand through cost-effective data analytics in telehealth.

By Application: Cardiovascular diseases constitute the largest segment with 30% market share, valued at USD 6.6 billion in 2023 and expected to expand to USD 33.0 billion by 2031, powered by arrhythmia research and prevalence trends. Diabetes holds 25% share, valued at USD 5.5 billion in 2023 and projected to reach USD 27.5 billion by 2031, fueled by CGM applications. Chronic respiratory conditions and others each account for 20% of the market, reflecting growing awareness of remote vital tracking benefits and targeted interventions.

By End-User: Payers lead with a commanding 40% market share, valued at USD 8.8 billion in 2023 and forecasted to reach USD 44.0 billion by 2031, favoured for their reimbursement models and population health management. Providers hold a 35% share, worth USD 7.7 billion in 2023 and projected to grow to USD 38.5 billion by 2031, attracting hospitals seeking reduced admissions. The remaining 25% comprises patients and homecare, growing fastest at 22.6% CAGR to USD 27.5 billion by 2031, catering to niche needs for self-monitoring and wellness apps.

Innovation and Consumer Trends Fueling Market Expansion

Manufacturers are investing heavily in advanced connectivity technologies, such as 5G-enabled sensors and AI predictive models, to improve data fidelity, reduce latency costs by an estimated 22%, and comply with regulatory expectations. Patient growth is driven by expanding awareness of RPM's role in independent living, integration into daily wearables, and education on secure, proactive health tools. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by clinical validations, insurer collaborations, and proven outcome-enhancing systems.

Market Outlook and Opportunities: The Global remote patient monitoring market is at a tipping point, driven by patient-centric mandates and every ounce of digital evolution in connected care. Valued at USD 50.2 billion in 2023, it is projected to reach USD 251.0 billion by 2031 at a steady 22.4% CAGR. North America, capturing nearly half the global share, spearheads expansion powered by chronic management demand, while Asia Pacific benefits from mobile penetration. Progress in wearable integrations and secure platforms align with HIPAA sustainability aims, although hurdles like data privacy breaches, interoperability challenges, and adoption barriers remain. Post-pandemic focus on home-based care and rising embrace of AI-driven alerts and personalized telehealth unlock vast potential for chronic oversight and efficiency gains in payers, providers, and homecare sectors.

Related Reports:

Patient Monitoring Accessories Market -
https://www.datamintelligence.com/download-sample/patient-monitoring-accessories-market?Nitin

Multiparameter Patient Monitoring Devices Market -
https://www.datamintelligence.com/download-sample/multiparameter-patient-monitoring-devices-market?nitin

Critical Care Equipment Market -
https://www.datamintelligence.com/download-sample/critical-care-equipment-market?nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.